Loading...
A Phase II Study of Campath-1H in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report
BACKGROUND: Despite the increasing cure rates for children with acute lymphoblastic leukemia (ALL), patients who relapse continue to have poor prognosis. The Children’s Oncology Group (COG) conducted a limited institution Phase II trial of Campath-1H, a monoclonal antibody that targets CD52 on leuke...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2009
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3120889/ https://ncbi.nlm.nih.gov/pubmed/19637330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22209 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|